SOJOURN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Sojourn, and what generic alternatives are available?
Sojourn is a drug marketed by Piramal Critical and is included in one NDA.
The generic ingredient in SOJOURN is sevoflurane. There are five drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the sevoflurane profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sojourn
A generic version of SOJOURN was approved as sevoflurane by BAXTER HLTHCARE on July 2nd, 2002.
Summary for SOJOURN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 92 |
| Clinical Trials: | 8 |
| Patent Applications: | 2,351 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | SOJOURN at DailyMed |
Recent Clinical Trials for SOJOURN
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Alberta Children's Hospital | Phase 2 |
| Emory University | Phase 4 |
| Alberta Children's Hospital | Phase 1 |
Pharmacology for SOJOURN
| Drug Class | General Anesthetic |
| Physiological Effect | General Anesthesia |
Anatomical Therapeutic Chemical (ATC) Classes for SOJOURN
US Patents and Regulatory Information for SOJOURN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Piramal Critical | SOJOURN | sevoflurane | LIQUID;INHALATION | 077867-001 | May 2, 2007 | AN | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
EU/EMA Drug Approvals for SOJOURN
| Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
|---|---|---|---|---|---|---|---|---|---|
| Chanelle Pharmaceuticals Manufacturing Limited | Sevohale (previously known as Sevocalm) | sevoflurane | EMEA/V/C/004199 For the induction and maintenance of anaesthesia. |
Authorised | yes | no | no | 2016-06-21 | |
| Zoetis Belgium SA | SevoFlo | sevoflurane | EMEA/V/C/000072 For the induction and maintenance of anaesthesia in dogs and cats. |
Authorised | no | no | no | 2002-12-11 | |
| >Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
